ANNUAL FINANCIALS

Financial results available for the following years:

Audited Standalone IND AS Financial Statements with Audit Report as on 31.03.2025

Audited Consolidated IND AS Financial Statements with Audit Report as on 31.03.2025

WINDLAS INC FY-25

AUDITED STANDALONE IND AS FINANCIAL STATEMENTS WITH AUDIT REPORT AS ON 31.03.2024

AUDITED CONSOLIDATED IND AS FINANCIAL STATEMENTS WITH AUDIT REPORT AS ON 31.03.2024

US Pharma Windlas LLC Financials March-2024

WINDLAS INC FY-24

AUDITED STANDALONE IND AS FINANCIAL STATEMENTS WITH AUDIT REPORT AS ON 31.03.2023

AUDITED CONSOLIDATED IND AS FINANCIAL STATEMENTS WITH AUDIT REPORT AS ON 31.03.2023

WINDLAS INC FY-23

US Pharma Windlas LLC Financials Mar-23

AUDITED STANDALONE INS AS FINANCIAL STATEMENTS WITH AUDIT REPORT AS ON 31.03.2022

AUDITED CONSOLIDATED IND AS FINANCIAL STATEMENTS WITH AUDIT REPORT AS ON 31.03.2022

WINDLAS INC FY 22

US Pharma Windlas LLC Financials Mar'22

AUDITED STANDALONE INS AS FINANCIAL STATEMENTS WITH AUDIT REPORT AS ON 31.03.2021

AUDITED CONSOLIDATED IND AS FINANCIAL STATEMENTS WITH AUDIT REPORT AS ON 31.03.2021

US Pharma Windlas LLC Financials Mar-21

WINDLAS BIOTECH

WINDLAS HEALTHCARE

WINDLAS BIOTECH

WINDLAS HEALTHCARE

WINDLAS BIOTECH

WINDLAS HEALTHCARE

Subscribe & Get More Information

Windlas Biotech Limited: Pioneering Pharma Solutions Globally | Empowering Healthier Lives | Authenticity and Affordability Redefined

About

Expertise

Services

Brands

Contact Info

Copyright ©2024 Windlas. All Rights Reserved.

About

Expertise

Services

Brands

About

Tel: 0124 282 1030
Tel: +91 135 6608000
Email: info@windlasbiotech.com,
grievance@windlasbiotech.com

©2023 Windlas. All Rights Reserved.

About

Services

Facilities

Products

Investor Relations

CSR

Career

Blog

Contact us

Windlas Biotech Limited
Corporate Identification Number : L74899UR2001PLC033407

Empowering innovation at Windlas Biotech – where advanced research meets sustainable solutions. Driven by science, we are dedicated to transforming health through pioneering biotech advancements and excellence in research and development.